BernadetteMarionCracchioloMD

Obstetrics & Gynecology • Newark, NJ

Gynecologic Oncology, Hospice & Palliative Medicine

Assistant Professor of Obstetrics & Gynecology, UMDNJ - New Jersey Medical School Newark

Join to view full profile

Dr. Cracchiolo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Cracchiolo's full profile

Already have an account?

Office
140 Bergen St
Acc Level C
Newark, NJ 07103
Phone+1 973-972-2700

Fax+1 973-972-2739

Education & Training

New York Presbyterian Hospital (Columbia Campus)Residency, Obstetrics and Gynecology, 1991 - 1995
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1991

Certifications & Licensure

NJ State Medical License 1997 - 2025
NY State Medical License 1999 - 2014
CT State Medical License 1995 - 1997
American Board of Internal Medicine Hospice and Palliative Medicine
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology
American Board of Preventive Medicine Addiction Medicine

Awards, Honors, & Recognition

Inside Jersey Magazine Top Doctors Castle Connolly, 2010-2014
Top Doctors: New York Metro Area Castle Connolly, 2009-2014
Inside Jersey Top Doctors for Cancer Castle Connolly, 2012, 2014
Inside Jersey - Top Doctors for Women's Health Castle Connolly, 2010-2012
NJ.com Top Doctors Castle Connolly, 2009
Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Join now to see all

Clinical Trials

Chemoprevention of Cancer in the Lower Female Genital Tract: The Antineoplastic Activity of the Fungicide Ciclopirox.
Withdrawn
Not Applicable
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer Start of enrollment: 2009 Apr 01
Completed
Phase 3
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Start of enrollment: 2009 Mar 23
Active, not recruiting
Phase 3
CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells Start of enrollment: 2009 Apr 13
Active, not recruiting
Not Applicable
Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer Start of enrollment: 2009 Sep 14
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

15 citations
Large cell neuroendocrine carcinoma of the cervix associated with adenocarcinoma in situ: evidence of a common origin
Shijun Cui, Pierre Lespinasse, Bernadette Cracchiolo, Jahir Sama, Michael S. Kreitzer
International Journal of Gynecological Pathology. 2001-07-01
73 citations
Blocking eIF5A modification in cervical cancer cells alters the expression of cancer-related genes and suppresses cell proliferation
Elisabeth Mémin, Mainul Hoque, Mohit Jain, Debra S. Heller, Hong Li
Cancer Research. 2014-01-15
22 citations
Epithelioid leiomyosarcoma of the ovary
Shondell M. Bouie, Bernadette Cracchiolo, Debra S. Heller
Gynecologic Oncology. 2005-05-01

Professional Memberships

American College of Obstetricians and Gynecologists
Fellow